Burvenich C - Search Results

1

Quality specifications for peptide drugs: a regulatory-pharmaceutical approach.

Vergote V, Burvenich C, Van de Wiele C, De Spiegeleer B. Vergote V, et al. Among authors: burvenich c. J Pept Sci. 2009 Nov;15(11):697-710. doi: 10.1002/psc.1167. J Pept Sci. 2009. PMID: 19750489 Review.

2

Adsorption of peptides at the sample drying step: influence of solvent evaporation technique, vial material and solution additive.

Pezeshki A, Vergote V, Van Dorpe S, Baert B, Burvenich C, Popkov A, De Spiegeleer B. Pezeshki A, et al. Among authors: burvenich c. J Pharm Biomed Anal. 2009 Apr 5;49(3):607-12. doi: 10.1016/j.jpba.2008.12.003. Epub 2008 Dec 11. J Pharm Biomed Anal. 2009. PMID: 19150589

3

Development of peptide receptor binding assays: methods to avoid false negatives.

Vergote V, Van Dorpe S, Verbeken M, Burvenich C, Van de Wiele C, Banks WA, De Spiegeleer B. Vergote V, et al. Among authors: burvenich c. Regul Pept. 2009 Nov 27;158(1-3):97-102. doi: 10.1016/j.regpep.2009.08.006. Epub 2009 Aug 23. Regul Pept. 2009. PMID: 19706310

4

Hydrophilic interaction LC of peptides: columns comparison and clustering.

Van Dorpe S, Vergote V, Pezeshki A, Burvenich C, Peremans K, De Spiegeleer B. Van Dorpe S, et al. Among authors: burvenich c. J Sep Sci. 2010 Mar;33(6-7):728-39. doi: 10.1002/jssc.200900476. J Sep Sci. 2010. PMID: 20135706

5

Brainpeps: the blood-brain barrier peptide database.

Van Dorpe S, Bronselaer A, Nielandt J, Stalmans S, Wynendaele E, Audenaert K, Van De Wiele C, Burvenich C, Peremans K, Hsuchou H, De Tré G, De Spiegeleer B. Van Dorpe S, et al. Among authors: burvenich c. Brain Struct Funct. 2012 Jul;217(3):687-718. doi: 10.1007/s00429-011-0375-0. Epub 2011 Dec 29. Brain Struct Funct. 2012. PMID: 22205159 Review.

6

A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products.

Suleman S, Vandercruyssen K, Wynendaele E, D'Hondt M, Bracke N, Duchateau L, Burvenich C, Peremans K, De Spiegeleer B. Suleman S, et al. Among authors: burvenich c. Malar J. 2013 Apr 30;12:145. doi: 10.1186/1475-2875-12-145. Malar J. 2013. PMID: 23631682 Free PMC article.

7

LC-UV/MS quality analytics of paediatric artemether formulations.

Vandercruyssen K, D'Hondt M, Vergote V, Jansen H, Burvenich C, De Spiegeleer B. Vandercruyssen K, et al. Among authors: burvenich c. J Pharm Anal. 2014 Feb;4(1):37-52. doi: 10.1016/j.jpha.2013.03.006. Epub 2013 Apr 25. J Pharm Anal. 2014. PMID: 29403867 Free PMC article.

8

LC-UV/MS characterization and DOE optimization of the iodinated peptide obestatin.

Vergote V, Baert B, Vandermeulen E, Peremans K, van Bree H, Slegers G, Burvenich C, De Spiegeleer B. Vergote V, et al. Among authors: burvenich c. J Pharm Biomed Anal. 2008 Jan 7;46(1):127-36. doi: 10.1016/j.jpba.2007.10.005. Epub 2007 Oct 13. J Pharm Biomed Anal. 2008. PMID: 18024048

9

Impurity profiling quality control testing of synthetic peptides using liquid chromatography-photodiode array-fluorescence and liquid chromatography-electrospray ionization-mass spectrometry: the obestatin case.

De Spiegeleer B, Vergote V, Pezeshki A, Peremans K, Burvenich C. De Spiegeleer B, et al. Among authors: burvenich c. Anal Biochem. 2008 May 15;376(2):229-34. doi: 10.1016/j.ab.2008.02.014. Epub 2008 Feb 23. Anal Biochem. 2008. PMID: 18342612

10

The potential role of quorum-sensing peptides in oncology.

Wynendaele E, Pauwels E, Van de Wiele C, Burvenich C, De Spiegeleer B. Wynendaele E, et al. Among authors: burvenich c. Med Hypotheses. 2012 Jun;78(6):814-7. doi: 10.1016/j.mehy.2012.03.018. Epub 2012 Apr 16. Med Hypotheses. 2012. PMID: 22513236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters